The Prevalence of Metabolic Associated Fatty Liver Disease in The Turkish Population: A Multicenter Study
| Autor: | Ahmet Uygun, Fehmi Ates, Seren Ozenirler, Yusuf Yilmaz, Emel Ahishali, Fatih Karakaya, Eda Kaya, Nimet Yılmaz, Ramazan Idilman, Hale Gokcan, İlker Şen, Gupse Adali, Aysun Kartal, Mehmet Koruk |
|---|---|
| Přispěvatelé: | Ahıshalı, Emel, Yılmaz, Yusuf, Yılmaz, Nimet, Ateş, Fehmi, Karakaya, Fatih, Gökcan, Hale, Kaya, Eda, Adali, Gupse, Kartal, Aysun Çalışkan, Şen, İlker, Özdemir, Seren, Koruk, Mehmet, Uygun, Ahmet, İdilman, Ramazan, Turkish Association for the Study of the Liver (TASL), Fatty Liver Diseases Special Interest Groups, School of Medicine |
| Rok vydání: | 2021 |
| Předmět: | |
| Zdroj: | Hepatology Forum |
| ISSN: | 1307-5888 |
| DOI: | 10.14744/hf.2021.2020.0033 |
| Popis: | Background and aim: the objective of the present study was to investigate the prevalence of metabolic-associated fatty liver disease (MAFLD) in patients with dyspepsia. Materials and methods: a total of 909 consecutive patients who presented with dyspepsia at 8 tertiary care centers in Turkey between March 2019 and December 2019 were included. Results: the median age was 47 years. Among them, 30.3% of the patients were obese, 18.8% had type 2 diabetes mellitus (T2DM), 35.1% had metabolic syndrome, 84.8% had dyslipidemia, and 23.9% had hypertension. The prevalence of MAFLD was 45.5%. Among the patients with MAFLD, the prevalence of obesity, T2DM, metabolic syndrome, dyslipidemia, and hypertension was 43.3%, 24.9%, 52.5%, 92.3%, and 31.9%, respectively. MAFLD was significantly associated with all of the metabolic comorbidities (p Turkish Association for the Study of the Liver and Fatty Liver Diseases Special Interest Groups |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|